AZD treatment did not improve obesity (body weight, Figure 4a, b), hyperglycaemia (Figure 4c, Supplementary Figure 4), hyperinsulinemia (Figure 4d) or insulin resistance (adiponectin, Supplementary Figure 4). This evidence concerns the gene ADIPOQ and hyperinsulinism.